Annual Drug Patent Expirations for BRUKINSA
Brukinsa is a drug marketed by Beigene and is included in one NDA. There is one patent protecting this drug.
This drug has twenty-three patent family members in twenty-four countries.
The generic ingredient in BRUKINSA is zanubrutinib. Additional details are available on the zanubrutinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
